Workflow
INNOVATE (VATE)
icon
Search documents
INNOVATE (VATE) - 2021 Q3 - Quarterly Report
2021-11-04 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-35210 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 54-1708481 (State or other jurisdiction of incorporation or organization) 295 Madison ...
INNOVATE (VATE) - 2021 Q2 - Earnings Call Presentation
2021-08-06 22:10
HC2 Holdings, Inc. Q2 2021 Earnings Release Supplement August 6, 2021 © HC2 HOLDINGS, INC. 2021 Safe Harbor Disclaimers Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains, and certain oral statements made by our representatives from time to time may contain, "forward-looking statements." Generally, forward-looking statements include information describing actions, events, results, strategies a ...
INNOVATE (VATE) - 2021 Q2 - Earnings Call Transcript
2021-08-06 21:08
HC2 Holdings, Inc. (HCHC) Q2 2021 Earnings Conference Call August 6, 2021 8:30 AM ET Company Participants Anthony Rozmus - Investor Relations Avie Glazer - Chairman Wayne Barr - Chief Executive Officer Mike Sena - Chief Financial Officer Conference Call Participants Brian Charles - R.W. Pressrich Derrick Wenger - Concise Capital Operator Good morning. And welcome to HC2 Holdings Second Quarter 2021 Earnings Conference Call. Today’s call is being recorded and we have allocated one hour for prepared remarks ...
INNOVATE (VATE) - 2021 Q2 - Quarterly Report
2021-08-06 11:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-35210 HC2 HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 54-1708481 (State or other jurisdiction of incorporation or organization) 295 Madison ...
INNOVATE (VATE) - 2021 Q1 - Earnings Call Presentation
2021-05-07 19:22
HC2 Holdings, Inc. Q1 2021 Earnings Release Supplement May 7, 2021 © HC2 HOLDINGS, INC. 2021 Safe Harbor Disclaimers Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains, and certain oral statements made by our representatives from time to time may contain, "forward-looking statements." Generally, forward-looking statements include information describing actions, events, results, strategies and ...
INNOVATE (VATE) - 2021 Q1 - Earnings Call Transcript
2021-05-07 15:53
HC2 Holdings, Inc. (HCHC) Q1 2021 Earnings Conference Call May 7, 2021 8:30 AM ET Company Participants Matt Chesler - FNK IR Wayne Barr - CEO Mike Sena - CFO Conference Call Participants Kevin O'Brien - Imperial Capital Brian Charles - R.W. Pressrich Richard Faulk - Centris Operator Greetings. Welcome to the HC2 Holdings’ Inc. First Quarter 2021 Earnings Call. At this time all participants are in a listen-only mode. A question and answer session will follow the formal presentation. [Operator Instructions] P ...
INNOVATE (VATE) - 2021 Q1 - Quarterly Report
2021-05-07 11:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-35210 HC2 HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 54-1708481 (State or other jurisdiction of incorporation or organization) 295 Madison ...
INNOVATE (VATE) - 2020 Q4 - Earnings Call Transcript
2021-03-11 03:31
HC2 Holdings, Inc. (HCHC) Q4 2020 Results Earnings Conference Call March 10, 2021 5:00 PM ET Company Participants Matt Chesler - FNK IR Avie Glazer - Chairman Wayne Barr - Chief Executive Officer Mike Sena - Chief Financial Officer Conference Call Participants Richter Yeske - Jefferies Booker Smith - Imperial Capital Operator Good afternoon. And welcome to the HCT -- HC2 Holdings’ Fourth Quarter and Year End ‘20 Earnings Conference Call. All participants will be in a listen-only more. After the prepared rem ...
INNOVATE (VATE) - 2020 Q4 - Annual Report
2021-03-10 21:54
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-35210 HC2 HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 54-1708481 (State or other jurisdiction of incorporation or organization) 450 Park Avenue, ...
INNOVATE (VATE) - 2020 Q3 - Earnings Call Transcript
2020-11-11 06:02
Financial Data and Key Metrics Changes - Consolidated total net revenue for Q3 2020 was $393.3 million, down from $427.5 million in the prior-year period, attributed to lower revenues from telecommunications, Infrastructure, Spectrum, and Insurance segments, partially offset by an increase in Clean Energy segment revenue [19] - Net loss attributable to common and participating preferred stockholders for Q3 2020 was $17.7 million or $0.38 per share, compared to a net loss of $7.5 million or $0.16 per share in the prior-year period [20] - Total adjusted EBITDA, excluding the Insurance segment, was $11.9 million in Q3 2020, comparable to the prior-year period [20] Business Line Data and Key Metrics Changes - Infrastructure segment generated adjusted EBITDA of $17.7 million in Q3 2020, down from $19.4 million in the prior-year period, impacted by project timing and COVID-related costs [21] - Clean Energy segment recorded adjusted EBITDA of $3.7 million in Q3 2020, up from $2.3 million in the prior-year period, benefiting from the renewal of the Alternative Fuels Tax Credit [24] - Insurance segment generated pretax adjusted operating income of $14.3 million in Q3 2020, compared to $13.5 million in the prior-year period, driven by favorable claims activity [25] Market Data and Key Metrics Changes - Infrastructure segment's reported backlog increased to $436 million, up from $410 million at the end of the second quarter, with adjusted backlog at $640 million [22] - Clean Energy revenue and adjusted EBITDA for Q4 2020 are expected to be well below Q4 2019 totals due to the retroactive nature of the Alternative Fuels Tax Credit renewal [24] Company Strategy and Development Direction - The company is focused on simplifying its portfolio, identifying businesses that can capitalize on market trends, and reducing debt through asset sales [7] - The rights offering of $65 million is a key step in improving the capital structure and is partially backstopped by major stockholders [15] - The company aims to build long-term value with its remaining assets after addressing capital structure issues [16] Management's Comments on Operating Environment and Future Outlook - Management noted the resilience of the business despite pandemic impacts and expressed optimism about the gradual economic rebound [6] - The company is actively exploring strategic alternatives for its Insurance segment and has completed the sale of its telecom subsidiary [12] - Management emphasized the importance of refinancing efforts to strengthen the balance sheet and maximize business value [17] Other Important Information - The company has reduced outstanding principal on its 11.5% notes by 27% since the beginning of 2020, resulting in annualized interest savings of $15 million [26] - Consolidated cash, cash equivalents, and investments totaled $4.7 billion, including $49 million in cash without the Insurance segment [25] Q&A Session All Questions and Answers Question: What are the likely pathways the board and management are considering for refinancing? - Management indicated that improving the overall capital structure is a priority, with the rights offering being a significant step, and they are exploring various refinancing options [33] Question: What are the explicit holding company-level cash requirements for the balance of the year? - The company expects about $22 million in interest costs and $3.5 million to $4 million in corporate SG&A expenses for the remaining months [35] Question: Can you provide more details on the backlog composition in the Infrastructure segment? - The backlog is primarily composed of small to medium-sized projects, with no significant customer or project concentration noted [41] Question: Can you provide any guidance on the outlook for Q4 and calendar year 2021? - Management does not provide specific guidance but expects some recovery in delayed maintenance and CapEx projects in 2021 [47] Question: What is the status of the rights offering? - The rights offering commenced at a market price of $2.27 and is open until November 20, with partial backstop support from major shareholders [51] Question: Were any dividends or management fees taken from the Insurance segment this quarter? - The company is pulling $1 million to $1.5 million a quarter in management fees from the Insurance segment [71] Question: What is the opportunity for the R2 device in Life Sciences? - Initial preorders for the R2 device are strong, indicating positive market reception, although specific quantitative guidance was not provided [72]